Humoral immunity in aging

Thoman M.L., Weigle W.O.: The cellular and subcellular bases of immunosenescence. Adv. Immunol. 46: 221–261, 1989.

Kishimoto S., Shinhachiro T., Mitsuya H., Fujiwara H., Tsuda H.: Age-related decline in the in vitro and in vivo synthesis of anti-tetanus toxoid antibody in humans. J. Immunol. 125: 2347–2352, 1980.

Hirokawa K.: Understanding the mechanism of the age-related decline in immune function. Nutr. Rev. 50: 361–366, 1992.

Ershler W.B., Herbert J.C., Blow A.J., Granter S.R., Lynch J.: Effect of thymosin alpha one on specific antibody response and susceptibility to infection in young and aged mice. Int. J. Immunopharmacol. 7: 465–471, 1985.

Hallgren H.M., Buckley C.E., Gilbersten V.A., Yunis E.J.: Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J. Immunol. 124: 1101–1111, 1973.

Hijmans W., Radl J., Bottazzo G.F., Doniach D.: Autoantibodies in highly aged humans. Mech. Ageing Dev. 26: 83–89, 1984.

Ligthart G.J., Radl J., Corberand J.X., Van Nieuwkoop J.E., Van Staalduinen G.J., Van Heimond D.J.W., Hijmans W.: Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech. Ageing Dev. 52: 235–243, 1990.

Hollenbaugh D., Grosmaire L.S., Kullas C.D., Chalupny N.J., Braesch-Andersen S., Noelle R.J., Stamenkovic I., Ledbetter J.A., Aruffo A.: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11: 4313–4321, 1992.

Rousset F., Garcia E., Banchereau J.: Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173: 705–710, 1991.

Korthauer U., Graf D., Mages H.W., Briére F., Padayachee M., Malcolm S., Ugazio A.G., Notarangelo L.D., Levinsky R.J., Kroczek R.A.: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539–541, 1993.

Snapper C.M., Mond J.J.: Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15–17, 1993.

Sutton B.J., Gould H.J.: The human IgE network. Nature 366: 421–428, 1993.

Defrance T., Carayon P., Billian G., Guillemot J.-C., Minty A., Caput D., Ferrara P.: Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179: 135–143, 1994.

Saxon A., Sidell N., Zhang K.: B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation. Cell. Immunol. 144: 169–181, 1992.

Radl J., Sepers J.M., Skvaril F., Morell A., Hijmans W.: Immunoglobulin patterns in humans over 95 years of age. Clin. Exp. Immunol. 22: 84–90, 1975.

Dworsky R., Paganini-Hill A., Arthur M., Parker J.: Immune responses of healthy humans 83–104 years of age. J. Nat. Cancer Inst. 71: 265–268, 1983.

Thompson J.S., Wekstein D.R., Rhoades J.L., Kirkpatrick C., Brown S.A., Roszman T., Straus R., Tietz N.: The immune status of healthy centenarians. J. Am. Geriatr. Soc. 32: 274–281, 1984.

Rabinowich H., Goses Y., Reshef T., Klajman A.: Interleukin-2 production and activity in aged humans. Mech. Ageing Dev. 32: 213–226, 1985.

Ligthart G.J., Corberand J.X., Fournier C., Garanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G.: Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 28: 47–55, 1984.

Paganelli R., Quinti I., Fagiolo U., Cossarizza A., Ortolani C., Guerra E., Sansoni P., Pucillo L.P., Scala E., Cozzi E., Bertollo L., Monti D., Franceschi C.: Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin. Exp. Immunol. 90: 351–354, 1990.

Skvaril F., Morell A., Perret B.: Clinical aspects of IgG subclasses and therapeutic implications. Monogr. Allergy 23, Karger, Basel, 1988.

Aalberse R.C., Van der Gaag R., Van Leewen J.: Serological aspects of IgG4: prolonged immunization results in an IgG4-restricted response. J. Immunol. 130: 722–726, 1983.

Ligthart G.J., Corberand J.X., Geertzen H.G., Meinders A.E., Knook D.L., Hijmans W.: Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech. Ageing Deu. 55: 89–105, 1990.

Lehtonen L., Eskola J., Vainio O., Lehtonen A.: Changes in lymphocyte subsets and immune competence in very advanced age. J. Gerontol. 45: M108–M112, 1990.

Suzuki K., Hirokawa K., Hatakeyama S.: Age-related change of distribution of immunoglobulin containing cells in human bone marrow. Changes in patients with benign monoclonal gammopathy and multiple myeloma. Virchows Archs. A 404: 243–251, 1984.

Ventura M.T.: Evaluation of IgA1–IgA2 levels in serum and saliva of young and elderly people. Immunol. Clin. 7: 135–140, 1988.

Fleming A.L., Field E.H., Tolaymat N., Cowdery J.S.: Age influences recovery of systemic and mucosal immune responses following acute depletion of CD4 T cells. Clin. Immunol. Immunopathol. 69: 285–291, 1993.

Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Macato A., Passeri G., Ortolani C., Forti E., Fagiolo U., Passeri M., Franceschi C.: Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 82: 2767–2772, 1993.

Mariotti S., Sansoni P., Barbesino G., Caturegli P., Monti D., Cossarizza A., Giacomelli T., Passeri G., Fagiolo U., Pinchera A., Franceschi C.: Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 339: 1506–1508, 1992.

Fagiolo U., Amadori A., Biselli R., Paganelli R., Nisini R., Cozzi E., Zamarchi R., D’Amelio R.: Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Vaccine 11: 1336–1340, 1993.

Kubo M., Cinader B.: Polymorphism of age-related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL 2, IL 3 and IL 4. Eur. J. Immunol. 20: 1289–1296, 1990.

Holbrook N.J., Chopra R.K., McCoy M.T., Nagel J.E., Powers D.C., Adler W.H., Schneider E.L.: Expression of interleukin 2 and the interleukin 2 receptor in aging rats. Cell. Immunol. 120: 1–9, 1989.

Cossarizza A., Monti D., Bersani F., Paganelli R., Montagnani G., Cadossi R., Cantini M., Franceschi C.: Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects. FEBS Lett. 248: 141–144, 1989.

Bryant A., Calver N.C., Toubi E., Webster A.D.B., Farrant J.: Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin. Immunol. Immunopathol. 56: 239–248, 1990.

Schorle H., Holtschke T., Hunig T., Schimpl A., Horak I.: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621–624, 1991.

Wei J., Xu H., Davies J.L., Hemmings G.P.: Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 51: 1953–1956, 1992.

Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.Z., Ryu S.Y.: Altered regulation of IL-6 production with normal aging. J. Immunol. 150: 5219–5230, 1993.

Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E., Monti D., Franceschi C., Paganelli R.: Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23: 2375–2378, 1993.

Hansson G.K., Jonasson L., Seifert P.S., Stemme S.: Immune mechanisms in atherosclerosis. Arteriosclerosis 9: 567–578, 1989.

Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M.: Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer’s disease cortices. FEBS Lett. 285: 111–114, 1991.

Kishimoto T.: The biology of interleukin-6. Blood 74: 1–10, 1989.

Hobbs M.V., Weigle W.O., Noonan D.J., Torbett B.E., McEvilly R.J., Koch R.J., Cardenas G.J., Ernst D.N: Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol. 150: 3602–3614, 1993.

Nagelkerken L., Hertogh-Hujibregts A., Dobber R., Drager A.: Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells. Eur. J. Immunol. 21: 273–281, 1991.

Cossarizza A., Ortolani C., Paganelli R., Monti D., Barbieri D., Sansoni P., Fagiolo U., Forti E., Londei M., Franceschi C.: Age-related imbalance of virgin (CD45RA+) and memory (CD45R0+) cells between CD4+ and CD8+ T lymphocytes in humans: a study from newborns to centenarians. J. Immunol. Res. 4: 118–126, 1992.

Geha R.S., Rosen F.S.: The genetic basis of immunoglobulin-class switching. N. Engl. J. Med. 330: 1008–1009, 1994.

Paul W.E., Seder R.A.: Lymphocyte responses and cytokines. Cell 76: 241–251, 1994.

Barbee R.A., Halonen M., Lebowitz M., Burrows B.: Distribution of IgE in a community population sample: correlations with age, sex and allergen skin reactivity. J. Allergy Clin. Immunol. 68: 106–111, 1981.

Paganelli R., Sgambato F., Carbonari M., Buono G., Bonomo R., Pontesilli O.: Cow’s milk hypersensitivity in an elderly woman: clinical and immunological findings. Ann. Allergy 56: 480–483, 1986.

Al-Rayes H., Pachas W., Mirza N., Ahern D.J., Geha R.S., Vercelli D.: IgE regulation and lymphokine patterns in aging humans. J. Allergy Clin. Immunol. 90: 630–636, 1992.

Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfati M., Hofstetter H., Kilcherr E., Debre P., Dalloul A.: Expression, structure, and function of the CD23 antigen. Adv. Immunol. 49: 149–191, 1991.

Kiniwa M., Gately M., Gubler U., Chizzonite R., Fargeas C., Delespesse G.: Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262–266, 1992.

Swain S.L., Bradley L.M., Croft M., Tonkonogy S., Atkins G., Weinberg A.D., Duncan D.D., Hedrick S.M., Dutton R.W., Huston G.: Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123: 115–144, 1991.

Posnett D.N., Sinha R., Kabak S., Russo C.: Clonal populations of T cells in normal elderly humans: the T cell equivalent to “benign monoclonal gammapathy”. J. Exp. Med. 179: 609–618, 1994.

Femandez-Botran R.: Soluble cytokine receptors: their role in immunoregulation. FASEB J. 5: 2567–2574, 1991.

Klein U., Kuppers R., Rajewsky K.: Human IgM+ IgD+ B cells, the major B cell subset in the peripheral blood, express VK genes with no or little somatic mutation throughout life. Eur. J. Immunol. 23: 3272–3277, 1993.